Treatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients

Simple item page
dc.contributor.authorO’Neil, Conar R
dc.contributor.authorPang, Jack XQ
dc.contributor.authorLee, Samuel S
dc.contributor.authorSwain, Mark G
dc.contributor.authorBurak, Kelly W
dc.contributor.authorKlein, Patricia
dc.contributor.authorMyers, Robert P
dc.contributor.authorKapler, Jeff
dc.contributor.authorGill, Michael J
dc.contributor.authorLabrie, Martin
dc.contributor.authorCoffin, Carla S
dc.date.accessioned2018-09-27T11:29:53Z
dc.date.available2018-09-27T11:29:53Z
dc.date.issued2015-01-01
dc.date.updated2018-09-27T11:29:53Z
dc.description.versionPeer Reviewed
dc.identifier.citationConar R O’Neil, Jack XQ Pang, Samuel S Lee, et al., “Treatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 26, no. 6, pp. 293-296, 2015. doi:10.1155/2015/974871
dc.identifier.doihttps://doi.org/10.1155/2015/974871
dc.identifier.urihttp://hdl.handle.net/1880/108167
dc.language.rfc3066en
dc.rights.holderCopyright © 2015 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleTreatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
CJIDMM.2015.974871.pdf
Size:
714.24 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications